POZ December 2017
POZ December 2017
In every issue, you’ll find the hottest topics of interest to our readers along with cutting-edge health information.
Also Available On:
Features
The POZ 100: Celebrating Women
The 2017 POZ 100 celebrates the contributions of women in the fight against HIV.
The POZ 100: A-C
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
The POZ 100: D-G
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
The POZ 100: H-K
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
The POZ 100: L-O
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
The POZ 100: P-S
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
The POZ 100: T-Z
The 2017 POZ 100 list celebrates the contributions of women in the fight against HIV.
Editor’s Letter
I Am Woman
I am not a woman, but I do feel energized whenever I hear songs of empowerment for women.
POZ Q+A
Justice For All
Immigration Equality advocates on behalf of both LGBT immigrants and all immigrants living with HIV.
POZ Planet
Weathering the Storms
HIV/AIDS groups offer emergency relief to hurricane-battered regions.
Puerto Rico Update
Our October cover story on Puerto Rico was published just days before Maria made landfall.
CDC Backs “U=U” Science
There’s effectively no risk of transmission from an HIV-positive partner to an HIV-negative partner when the virus is fully suppressed.
A New Day With(out) Art
Visual AIDS commissions seven videos of Black narratives within the epidemic.
Modernizing HIV Crime Laws
January 1, 2018, will mark a new dawn for HIV crime laws in California, thanks to a law signed by Governor Jerry Brown.
Discussing 90 Days
Love is the message in this short film about HIV, disclosure and dating.
Voices
Question Motives
HIV researcher David Alain Wohl, MD, urges AIDS activists to be a vanguard against indifference, overreach and shortsightedness.
Around the Edges
Writer Anna Forbes responds to an open letter by HIV researcher David Alain Wohl, MD, that urges AIDS activists to do more.
Spotlight
USCA 2017
The social media buzz on the 21st United States Conference on AIDS.
POZ Survey Says
Handle With Care
The results of our POZ Survey on self-care are in.
Research Notes
Prevention: PrEP Success/Failure
Leaders at Kaiser Permanente Northern California want to broaden the definition of “PrEP failure."
Treatment: Long-Acting Drugs
A recent study tested the long-acting injectable antiretrovirals cabotegravir and Edurant (rilpivirine) given every four or eight weeks.
Cure: Viral Remission
Scientists are investigating how the apparent size of an individual’s reservoir may help predict the length of viral remission.
Concerns: Youth Risk
Youths on HIV meds may episodically develop a significant risk of transmitting the virus.
Care and Treatment
Nearly Half of U.S. HIV Population is Undetectable
The CDC estimates that of the 1.1 million U.S. residents living with HIV in 2014, 49 percent had an undetectable viral load.
Statins—An Underused Lifesaver?
Even when HIV is fully suppressed, the virus is associated with as much as double the risk of cardiovascular disease (CVD).
Liver Fibrosis and Fatty Liver Risks
Among people with HIV who don’t have hepatitis C virus, various factors raise the risk of liver fibrosis (scarring) and fatty liver disease.
Identifying Those Likely to Most Benefit From Hep C Cure
Curing HCV in those coinfected with HIV provides the greatest chance to reduce the risk of death among those who have advanced fibrosis.
Heroes
Beyond Ourselves
Jesús Aguais is the founder and executive director of Aid for AIDS.
